On Friday, 89bio Inc (NASDAQ: ETNB) opened lower -11.43% from the last session, before settling in for the closing price of $7.35. Price fluctuations for ETNB have ranged from $6.43 to $16.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -58.97% at the time writing. With a float of $112.63 million, this company’s outstanding shares have now reached $117.58 million.
In an organization with 70 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.19%, operating margin of -129853.42%, and the pretax margin is -121648.72%.
89bio Inc (ETNB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 89bio Inc is 4.21%, while institutional ownership is 92.43%. The most recent insider transaction that took place on Dec 06 ’24, was worth 39,450. In this transaction Chief Executive Officer of this company bought 5,000 shares at a rate of $7.89, taking the stock ownership to the 471,236 shares. Before that another transaction happened on Dec 05 ’24, when Company’s Director bought 10,000 for $8.00, making the entire transaction worth $80,000. This insider now owns 10,000 shares in total.
89bio Inc (ETNB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -58.97% per share during the next fiscal year.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Check out the current performance indicators for 89bio Inc (ETNB). In the past quarter, the stock posted a quick ratio of 11.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.91, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.93 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.7 million. That was inferior than the volume of 0.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.33%. Additionally, its Average True Range was 0.51.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 5.61%, which indicates a significant decrease from 13.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.93% in the past 14 days, which was higher than the 65.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.34, while its 200-day Moving Average is $8.53. However, in the short run, 89bio Inc’s stock first resistance to watch stands at $7.13. Second resistance stands at $7.74. The third major resistance level sits at $8.18. If the price goes on to break the first support level at $6.08, it is likely to go to the next support level at $5.64. The third support level lies at $5.03 if the price breaches the second support level.
89bio Inc (NASDAQ: ETNB) Key Stats
There are currently 106,126K shares outstanding in the company with a market cap of 765.46 million. Presently, the company’s annual sales total 0 K according to its annual income of -142,190 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -149,070 K.
